Delivery Order SPE2DB22D3004-SPE2DB24FRG65
Award Date
8/2/24
Potential Completion Date
8/5/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,228.36 firm-fixed-price delivery order is for the supply of 4,565,119,617 units of the prescription medication Nalbuphine 100 mg/10 ml vial. The contract has a completion date of July 12, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,366.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML medical supplies, with a performance period ending on December 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,824.74 firm fixed-price delivery order is for the supply of 10 mL vials of the medication Nalbuphine 200 mg. The contract has a completion date of July 5, 2024 and was awarded on July 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,887.80 and a completion date of February 3, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award, valued at $1,496.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALBUPHINE 200 MG/10 ML VIAL 10ML, a medical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,007.26, is for the delivery of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pain management medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of March 31, 2025. This award is not designated as a set-aside contract. The contract award is...
This federal contract award, valued at $4,237.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567286025 - NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through February 18, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
The federal contract award is for the delivery of Nalbuphine 100 mg/10 ml vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,473.54 and an ultimate completion date of December 29, 2023. This award is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award, valued at $78,513.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4539361389 units of Nalbuphine 10ML 25S, a pharmaceutical product, with an ultimate completion date of October 13, 2017. The contract is structured as a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen...
This federal contract award is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,271.25 and is a Firm Fixed Price Delivery Order with a completion date of November 1, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...